You have 9 free searches left this month | for more free features.

City

Detroit (2)

Atlanta (1)

Bethesda (1)

Oakland (1)

Philadelphia (1)

Sacramento (1)

Condition

Blood and Lymphatic Diseases (1)

Sickle Cell Disease (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Sangamo Therapeutics (2)

Collaborator

Intervention

bivv003 (2)

busulfan (1)

plerixafor (1)

st-400 (1)

Study Documents

Intervention Type

drug (2)

biological (1)

genetic (1)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational (1)

bivv003

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

Recruiting

Blood and Lymphatic Diseases

BIVV003
ST-400

Detroit, Michigan

Investigational Site Number :8400001

Jul 6, 2022

Sickle Cell Disease Trial in United States (biological, drug, genetic)

Recruiting

Sickle Cell Disease

Plerixafor
+2 more

Oakland, California
+5 more

Sep 13, 2022